Clinical Trial Update: Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating pyrotinib combined with trastuzumab and chemotherapy as neoadjuvant therapy for HER2-positive breast cancer, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pyrotinib (pyrotinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Youzhi Zhu | Conditions: Breast Cancer Female | NA | Status: RECRUITING